How Martina took part in a clinical trial for breast cancer treatment and encourages more people to do the same.

Story
Published: 30 June 2025
Martina was diagnosed with breast cancer in 2019. She took part in a clinical trial and now is encouraging more people from ethnically diverse communities to take part in them.

Meet Martina

My name is Martina Warner. I'm 49 years old. I am a mother of three and I live with my partner. 

Diagnosis 

 

In 2019, I was diagnosed with breast cancer cells. And unfortunately, I was diagnosed with the worst strain of the breast cancers, which is a triple negative breast cancer

I'd finished my treatment, which consisted of the chemotherapy, then radiotherapy. And then about 18 months later, I started getting symptoms again. My Nurse booked me in for an MRI and CT scan, which revealed that I had a tumour in my lung and liver. My next treatment was going to be intravenous chemotherapy. It was that time that I decided to seek a second opinion. 

My doctor suggested I join a Facebook group specifically for triple negative breast cancer. I found a wealth of information from a lot of the patients there, as opposed to the oncologists themselves. 

I met a lady who was on a trial drug. I'd never heard of trial drugs before. I put forward my diagnosis to her, and she said, look, there were trials going on at Barts. She strongly recommended that I consider them. I call her my guardian angel. Unfortunately, she's no longer with us, but because of her, this is why I'm still here. Because I made that decision to go ahead with the trial drug.   

Watch Martina tell her story in the video below

[VIDEO]

Translated versions:

 

I'm still here. Because I made that decision to go ahead with the trial drug.

Taking part in clinical trials 

 

I was given hard core facts and reality. But it's a risk that I wanted to take because I was at my tether. I was desperate because I could literally feel myself dying. 

I had agreed after the consultation to go ahead with the trial, but I had to be fit enough to then start the trial. This is going to sound really bizarre, but I was just elated and jumping for joy. Nobody wants to be on chemotherapy. 

It was all about survival. I was given the right information by the professor. They answered all my questions. I did my research with a clinical nurse, and they said trial drugs are actually monitored much more closely than your bog standard, licensed chemotherapy drug so, I felt safe and confident. 

And I don't think I would be here had I not taken that up. 

Clinical trials is something that I would strongly encourage because I'm living proof, you know, that these things work for a period of time. It gave me two years of life and so I strongly encourage our communities, ethnic minorities to give it a go. 

I'd like to see more of our community involved, in trial drugs and to encourage us to be more involved. 

Working to address ethnic inequalities in breast cancer clinical trials

Macmillan Cancer Support, Roche, and the NHS Race and Health Observatory (NHSRHO) are working in collaboration to address ethnic inequalities in breast cancer clinical trials. The project aims to increase representation, improve patient retention, and generate evidence to support improved recruitment of ethnic minority patients. The project is being piloted at Barts Health NHS Trust.

Find out more about the project [link to leaflet]

or email Barts Health NHS Trust

We have more information about clinical trials.

More stories like this